nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—SLCO1B1—breast cancer	0.107	0.343	CbGaD
Cyclosporine—ABCC1—breast cancer	0.0887	0.284	CbGaD
Cyclosporine—ABCG2—breast cancer	0.0468	0.149	CbGaD
Cyclosporine—CYP2D6—breast cancer	0.0273	0.0871	CbGaD
Cyclosporine—CYP3A4—breast cancer	0.0234	0.0747	CbGaD
Cyclosporine—ABCB1—breast cancer	0.0195	0.0622	CbGaD
Cyclosporine—ABCC1—Idarubicin—breast cancer	0.0171	0.0431	CbGbCtD
Cyclosporine—ABCC10—Gemcitabine—breast cancer	0.0168	0.0424	CbGbCtD
Cyclosporine—SLCO1A2—Chlorambucil—breast cancer	0.0153	0.0384	CbGbCtD
Cyclosporine—ABCC10—Paclitaxel—breast cancer	0.0152	0.0383	CbGbCtD
Cyclosporine—ABCC10—Docetaxel—breast cancer	0.011	0.0277	CbGbCtD
Cyclosporine—ABCB11—Tamoxifen—breast cancer	0.0106	0.0267	CbGbCtD
Cyclosporine—ABCC3—Fluorouracil—breast cancer	0.00905	0.0228	CbGbCtD
Cyclosporine—ABCB11—Paclitaxel—breast cancer	0.00826	0.0208	CbGbCtD
Cyclosporine—ABCC10—Doxorubicin—breast cancer	0.00819	0.0206	CbGbCtD
Cyclosporine—ABCC10—Methotrexate—breast cancer	0.00793	0.02	CbGbCtD
Cyclosporine—ABCC1—Mitoxantrone—breast cancer	0.00735	0.0185	CbGbCtD
Cyclosporine—ABCB11—Vinblastine—breast cancer	0.00724	0.0182	CbGbCtD
Cyclosporine—ABCC1—Epirubicin—breast cancer	0.00595	0.015	CbGbCtD
Cyclosporine—ABCC1—Paclitaxel—breast cancer	0.00587	0.0148	CbGbCtD
Cyclosporine—ABCC1—Irinotecan—breast cancer	0.00579	0.0146	CbGbCtD
Cyclosporine—CYP2C9—Anastrozole—breast cancer	0.00561	0.0141	CbGbCtD
Cyclosporine—CYP3A5—Lapatinib—breast cancer	0.00558	0.0141	CbGbCtD
Cyclosporine—ABCC2—Tamoxifen—breast cancer	0.00558	0.014	CbGbCtD
Cyclosporine—CYP2C8—Lapatinib—breast cancer	0.00537	0.0135	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—breast cancer	0.00515	0.013	CbGbCtD
Cyclosporine—ABCC1—Vinblastine—breast cancer	0.00515	0.013	CbGbCtD
Cyclosporine—ABCG2—Tamoxifen—breast cancer	0.00504	0.0127	CbGbCtD
Cyclosporine—ABCC3—Methotrexate—breast cancer	0.00499	0.0126	CbGbCtD
Cyclosporine—ABCB1—Toremifene—breast cancer	0.00498	0.0125	CbGbCtD
Cyclosporine—ABCG2—Mitoxantrone—breast cancer	0.00492	0.0124	CbGbCtD
Cyclosporine—SLCO1B1—Irinotecan—breast cancer	0.00487	0.0123	CbGbCtD
Cyclosporine—CYP2C19—Lapatinib—breast cancer	0.0045	0.0113	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—breast cancer	0.00445	0.0112	CbGbCtD
Cyclosporine—ABCC2—Paclitaxel—breast cancer	0.00434	0.0109	CbGbCtD
Cyclosporine—CYP3A4—Exemestane—breast cancer	0.0043	0.0108	CbGbCtD
Cyclosporine—ABCC2—Irinotecan—breast cancer	0.00428	0.0108	CbGbCtD
Cyclosporine—CYP2C9—Idarubicin—breast cancer	0.00425	0.0107	CbGbCtD
Cyclosporine—ABCC1—Docetaxel—breast cancer	0.00424	0.0107	CbGbCtD
Cyclosporine—ABCC2—Carboplatin—breast cancer	0.00409	0.0103	CbGbCtD
Cyclosporine—CYP2C8—Raloxifene—breast cancer	0.00407	0.0102	CbGbCtD
Cyclosporine—ABCG2—Paclitaxel—breast cancer	0.00393	0.00989	CbGbCtD
Cyclosporine—CYP2D6—Idarubicin—breast cancer	0.00389	0.00979	CbGbCtD
Cyclosporine—ABCG2—Irinotecan—breast cancer	0.00387	0.00975	CbGbCtD
Cyclosporine—ABCC2—Vinblastine—breast cancer	0.00381	0.00959	CbGbCtD
Cyclosporine—CYP3A7—Tamoxifen—breast cancer	0.00372	0.00938	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00372	0.00938	CbGbCtD
Cyclosporine—ABCG2—Fluorouracil—breast cancer	0.00372	0.00936	CbGbCtD
Cyclosporine—ABCG2—Carboplatin—breast cancer	0.00369	0.0093	CbGbCtD
Cyclosporine—CYP3A4—Letrozole—breast cancer	0.00366	0.00922	CbGbCtD
Cyclosporine—ABCB1—Lapatinib—breast cancer	0.00363	0.00915	CbGbCtD
Cyclosporine—CYP3A4—Anastrozole—breast cancer	0.00326	0.00821	CbGbCtD
Cyclosporine—ABCC1—Doxorubicin—breast cancer	0.00316	0.00796	CbGbCtD
Cyclosporine—ABCC2—Docetaxel—breast cancer	0.00314	0.00791	CbGbCtD
Cyclosporine—ABCC1—Methotrexate—breast cancer	0.00306	0.00771	CbGbCtD
Cyclosporine—CYP3A4—Toremifene—breast cancer	0.00298	0.00751	CbGbCtD
Cyclosporine—CYP3A7—Paclitaxel—breast cancer	0.0029	0.0073	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.0029	0.0073	CbGbCtD
Cyclosporine—CYP3A7—Irinotecan—breast cancer	0.00286	0.0072	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00286	0.0072	CbGbCtD
Cyclosporine—ABCG2—Docetaxel—breast cancer	0.00284	0.00715	CbGbCtD
Cyclosporine—CYP3A5—Tamoxifen—breast cancer	0.00279	0.00704	CbGbCtD
Cyclosporine—CYP3A4—Fulvestrant—breast cancer	0.00277	0.00698	CbGbCtD
Cyclosporine—SLCO1A2—Methotrexate—breast cancer	0.00273	0.00689	CbGbCtD
Cyclosporine—CYP2C8—Tamoxifen—breast cancer	0.00269	0.00677	CbGbCtD
Cyclosporine—SLCO1B1—Methotrexate—breast cancer	0.00258	0.0065	CbGbCtD
Cyclosporine—CYP3A4—Thiotepa—breast cancer	0.00247	0.00622	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—breast cancer	0.00234	0.00589	CbGbCtD
Cyclosporine—CYP2C9—Capecitabine—breast cancer	0.00233	0.00587	CbGbCtD
Cyclosporine—ABCC2—Methotrexate—breast cancer	0.00227	0.00571	CbGbCtD
Cyclosporine—CYP3A4—Ixabepilone—breast cancer	0.00226	0.00569	CbGbCtD
Cyclosporine—CYP2C19—Tamoxifen—breast cancer	0.00225	0.00568	CbGbCtD
Cyclosporine—CYP3A4—Lapatinib—breast cancer	0.00218	0.00548	CbGbCtD
Cyclosporine—CYP3A5—Paclitaxel—breast cancer	0.00217	0.00548	CbGbCtD
Cyclosporine—CYP3A5—Irinotecan—breast cancer	0.00215	0.0054	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—breast cancer	0.00212	0.00533	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.0021	0.00528	CbGbCtD
Cyclosporine—CYP3A7—Docetaxel—breast cancer	0.0021	0.00528	CbGbCtD
Cyclosporine—CYP2C8—Paclitaxel—breast cancer	0.00209	0.00527	CbGbCtD
Cyclosporine—ABCG2—Methotrexate—breast cancer	0.00205	0.00516	CbGbCtD
Cyclosporine—ABCB1—Vinorelbine—breast cancer	0.00201	0.00507	CbGbCtD
Cyclosporine—CYP2C8—Fluorouracil—breast cancer	0.00198	0.00499	CbGbCtD
Cyclosporine—CYP2D6—Vinorelbine—breast cancer	0.0019	0.00478	CbGbCtD
Cyclosporine—CYP2C9—Tamoxifen—breast cancer	0.00187	0.00472	CbGbCtD
Cyclosporine—ABCB1—Tamoxifen—breast cancer	0.00182	0.00458	CbGbCtD
Cyclosporine—ABCB1—Mitoxantrone—breast cancer	0.00177	0.00447	CbGbCtD
Cyclosporine—FKBP4—Estradiol—Fulvestrant—breast cancer	0.00173	1	CbGdCrCtD
Cyclosporine—CYP2D6—Tamoxifen—breast cancer	0.00171	0.00432	CbGbCtD
Cyclosporine—SLC22A6—Methotrexate—breast cancer	0.00166	0.00418	CbGbCtD
Cyclosporine—CYP3A4—Raloxifene—breast cancer	0.00165	0.00415	CbGbCtD
Cyclosporine—CYP3A5—Docetaxel—breast cancer	0.00157	0.00396	CbGbCtD
Cyclosporine—ABCB1—Gemcitabine—breast cancer	0.00157	0.00395	CbGbCtD
Cyclosporine—CYP2C9—Paclitaxel—breast cancer	0.00146	0.00367	CbGbCtD
Cyclosporine—ABCB1—Paclitaxel—breast cancer	0.00142	0.00356	CbGbCtD
Cyclosporine—ABCB1—Irinotecan—breast cancer	0.0014	0.00352	CbGbCtD
Cyclosporine—CYP2C9—Fluorouracil—breast cancer	0.00138	0.00348	CbGbCtD
Cyclosporine—PPP3R2—female reproductive system—breast cancer	0.00135	0.0243	CbGeAlD
Cyclosporine—ABCB1—Vinblastine—breast cancer	0.00124	0.00313	CbGbCtD
Cyclosporine—FKBP4—mammary gland—breast cancer	0.00124	0.0223	CbGeAlD
Cyclosporine—CYP3A4—Vinorelbine—breast cancer	0.00121	0.00304	CbGbCtD
Cyclosporine—CYP2D6—Vinblastine—breast cancer	0.00117	0.00295	CbGbCtD
Cyclosporine—PPP3R2—endocrine gland—breast cancer	0.00114	0.0205	CbGeAlD
Cyclosporine—CYP3A4—Tamoxifen—breast cancer	0.00109	0.00274	CbGbCtD
Cyclosporine—CYP3A4—Mitoxantrone—breast cancer	0.00106	0.00268	CbGbCtD
Cyclosporine—PPIA—mammary gland—breast cancer	0.00102	0.0184	CbGeAlD
Cyclosporine—ABCB1—Docetaxel—breast cancer	0.00102	0.00258	CbGbCtD
Cyclosporine—PPID—nipple—breast cancer	0.000943	0.017	CbGeAlD
Cyclosporine—CAMLG—nipple—breast cancer	0.000929	0.0168	CbGeAlD
Cyclosporine—CYP3A4—Paclitaxel—breast cancer	0.000848	0.00214	CbGbCtD
Cyclosporine—PPIA—nipple—breast cancer	0.000847	0.0153	CbGeAlD
Cyclosporine—FKBP4—embryo—breast cancer	0.000843	0.0152	CbGeAlD
Cyclosporine—FKBP1B—adipose tissue—breast cancer	0.000841	0.0152	CbGeAlD
Cyclosporine—CYP3A4—Irinotecan—breast cancer	0.000837	0.00211	CbGbCtD
Cyclosporine—PPIF—mammary gland—breast cancer	0.000829	0.0149	CbGeAlD
Cyclosporine—PPP3CA—mammary gland—breast cancer	0.000794	0.0143	CbGeAlD
Cyclosporine—ABCB1—Doxorubicin—breast cancer	0.000763	0.00192	CbGbCtD
Cyclosporine—FKBP1B—adrenal gland—breast cancer	0.000754	0.0136	CbGeAlD
Cyclosporine—CYP3A4—Vinblastine—breast cancer	0.000744	0.00187	CbGbCtD
Cyclosporine—ABCB1—Methotrexate—breast cancer	0.000739	0.00186	CbGbCtD
Cyclosporine—CYP2D6—Doxorubicin—breast cancer	0.000719	0.00181	CbGbCtD
Cyclosporine—FKBP1B—female gonad—breast cancer	0.000703	0.0127	CbGeAlD
Cyclosporine—PPIF—nipple—breast cancer	0.000686	0.0124	CbGeAlD
Cyclosporine—PPP3CA—nipple—breast cancer	0.000656	0.0118	CbGeAlD
Cyclosporine—FKBP4—skin of body—breast cancer	0.000654	0.0118	CbGeAlD
Cyclosporine—PPIB—nipple—breast cancer	0.000653	0.0118	CbGeAlD
Cyclosporine—CYP3A4—Docetaxel—breast cancer	0.000613	0.00154	CbGbCtD
Cyclosporine—PPID—endometrium—breast cancer	0.000569	0.0103	CbGeAlD
Cyclosporine—FKBP4—uterus—breast cancer	0.000568	0.0102	CbGeAlD
Cyclosporine—CAMLG—endometrium—breast cancer	0.000561	0.0101	CbGeAlD
Cyclosporine—FKBP4—adipose tissue—breast cancer	0.000556	0.01	CbGeAlD
Cyclosporine—FKBP1A—mammary gland—breast cancer	0.000527	0.0095	CbGeAlD
Cyclosporine—CAMLG—uterus—breast cancer	0.000517	0.00932	CbGeAlD
Cyclosporine—PPID—pituitary gland—breast cancer	0.000515	0.00928	CbGeAlD
Cyclosporine—PPID—adipose tissue—breast cancer	0.000513	0.00925	CbGeAlD
Cyclosporine—PPIA—endometrium—breast cancer	0.000511	0.00921	CbGeAlD
Cyclosporine—FKBP4—female reproductive system—breast cancer	0.000511	0.00921	CbGeAlD
Cyclosporine—CAMLG—pituitary gland—breast cancer	0.000508	0.00915	CbGeAlD
Cyclosporine—CAMLG—adipose tissue—breast cancer	0.000506	0.00912	CbGeAlD
Cyclosporine—FKBP4—adrenal gland—breast cancer	0.000499	0.00899	CbGeAlD
Cyclosporine—PPID—female reproductive system—breast cancer	0.000472	0.0085	CbGeAlD
Cyclosporine—PPIA—uterus—breast cancer	0.000471	0.00849	CbGeAlD
Cyclosporine—FKBP4—female gonad—breast cancer	0.000465	0.00838	CbGeAlD
Cyclosporine—CAMLG—female reproductive system—breast cancer	0.000465	0.00838	CbGeAlD
Cyclosporine—PPIA—pituitary gland—breast cancer	0.000463	0.00834	CbGeAlD
Cyclosporine—PPIA—adipose tissue—breast cancer	0.000461	0.0083	CbGeAlD
Cyclosporine—PPID—adrenal gland—breast cancer	0.00046	0.00829	CbGeAlD
Cyclosporine—CYP3A4—Doxorubicin—breast cancer	0.000457	0.00115	CbGbCtD
Cyclosporine—CAMLG—adrenal gland—breast cancer	0.000454	0.00818	CbGeAlD
Cyclosporine—FKBP1B—lymph node—breast cancer	0.000452	0.00815	CbGeAlD
Cyclosporine—SLCO1B1—mammary gland—breast cancer	0.000447	0.00806	CbGeAlD
Cyclosporine—PPID—bone marrow—breast cancer	0.000445	0.00802	CbGeAlD
Cyclosporine—PPIB—epithelium—breast cancer	0.000439	0.00792	CbGeAlD
Cyclosporine—PPIF—skin of body—breast cancer	0.000439	0.00791	CbGeAlD
Cyclosporine—CAMLG—bone marrow—breast cancer	0.000439	0.00791	CbGeAlD
Cyclosporine—SLC10A2—endocrine gland—breast cancer	0.000436	0.00786	CbGeAlD
Cyclosporine—FKBP1A—nipple—breast cancer	0.000436	0.00786	CbGeAlD
Cyclosporine—FKBP4—endocrine gland—breast cancer	0.000432	0.00779	CbGeAlD
Cyclosporine—PPID—female gonad—breast cancer	0.000429	0.00773	CbGeAlD
Cyclosporine—CAMLG—female gonad—breast cancer	0.000423	0.00762	CbGeAlD
Cyclosporine—PPIB—skin of body—breast cancer	0.000418	0.00753	CbGeAlD
Cyclosporine—PPIF—endometrium—breast cancer	0.000414	0.00746	CbGeAlD
Cyclosporine—PPIA—adrenal gland—breast cancer	0.000413	0.00745	CbGeAlD
Cyclosporine—PPIA—bone marrow—breast cancer	0.0004	0.0072	CbGeAlD
Cyclosporine—PPID—endocrine gland—breast cancer	0.000399	0.00719	CbGeAlD
Cyclosporine—PPP3CA—endometrium—breast cancer	0.000396	0.00714	CbGeAlD
Cyclosporine—PPIB—endometrium—breast cancer	0.000394	0.0071	CbGeAlD
Cyclosporine—CAMLG—endocrine gland—breast cancer	0.000393	0.00709	CbGeAlD
Cyclosporine—PPIA—female gonad—breast cancer	0.000385	0.00694	CbGeAlD
Cyclosporine—PPIF—uterus—breast cancer	0.000381	0.00687	CbGeAlD
Cyclosporine—PPIF—pituitary gland—breast cancer	0.000375	0.00675	CbGeAlD
Cyclosporine—PPIF—adipose tissue—breast cancer	0.000373	0.00672	CbGeAlD
Cyclosporine—PPP3CA—uterus—breast cancer	0.000365	0.00658	CbGeAlD
Cyclosporine—PPIB—uterus—breast cancer	0.000363	0.00654	CbGeAlD
Cyclosporine—PPP3CA—pituitary gland—breast cancer	0.000359	0.00646	CbGeAlD
Cyclosporine—PPP3CA—adipose tissue—breast cancer	0.000357	0.00644	CbGeAlD
Cyclosporine—PPIB—pituitary gland—breast cancer	0.000357	0.00643	CbGeAlD
Cyclosporine—PPIB—adipose tissue—breast cancer	0.000355	0.0064	CbGeAlD
Cyclosporine—ABCC10—nipple—breast cancer	0.000349	0.0063	CbGeAlD
Cyclosporine—PPIF—female reproductive system—breast cancer	0.000343	0.00618	CbGeAlD
Cyclosporine—PPIF—adrenal gland—breast cancer	0.000335	0.00603	CbGeAlD
Cyclosporine—PPP3CA—female reproductive system—breast cancer	0.000328	0.00592	CbGeAlD
Cyclosporine—PPIB—female reproductive system—breast cancer	0.000326	0.00588	CbGeAlD
Cyclosporine—PPIF—bone marrow—breast cancer	0.000324	0.00583	CbGeAlD
Cyclosporine—PPP3CA—adrenal gland—breast cancer	0.00032	0.00577	CbGeAlD
Cyclosporine—PPIB—adrenal gland—breast cancer	0.000319	0.00574	CbGeAlD
Cyclosporine—PPIF—female gonad—breast cancer	0.000312	0.00562	CbGeAlD
Cyclosporine—PPP3CA—bone marrow—breast cancer	0.00031	0.00559	CbGeAlD
Cyclosporine—PPIB—bone marrow—breast cancer	0.000308	0.00555	CbGeAlD
Cyclosporine—FKBP4—lymph node—breast cancer	0.000299	0.00539	CbGeAlD
Cyclosporine—PPP3CA—female gonad—breast cancer	0.000299	0.00538	CbGeAlD
Cyclosporine—PPIB—female gonad—breast cancer	0.000297	0.00535	CbGeAlD
Cyclosporine—FKBP1A—epithelium—breast cancer	0.000294	0.00529	CbGeAlD
Cyclosporine—PPIF—endocrine gland—breast cancer	0.00029	0.00523	CbGeAlD
Cyclosporine—FKBP1A—skin of body—breast cancer	0.000279	0.00503	CbGeAlD
Cyclosporine—SLC10A1—female reproductive system—breast cancer	0.000279	0.00503	CbGeAlD
Cyclosporine—PPP3CA—endocrine gland—breast cancer	0.000278	0.00501	CbGeAlD
Cyclosporine—PPIB—endocrine gland—breast cancer	0.000276	0.00498	CbGeAlD
Cyclosporine—PPID—lymph node—breast cancer	0.000276	0.00497	CbGeAlD
Cyclosporine—CAMLG—lymph node—breast cancer	0.000272	0.0049	CbGeAlD
Cyclosporine—FKBP1A—endometrium—breast cancer	0.000263	0.00475	CbGeAlD
Cyclosporine—CYP2C8—mammary gland—breast cancer	0.000254	0.00458	CbGeAlD
Cyclosporine—PPIA—lymph node—breast cancer	0.000248	0.00446	CbGeAlD
Cyclosporine—ABCC1—nipple—breast cancer	0.000247	0.00445	CbGeAlD
Cyclosporine—FKBP1A—uterus—breast cancer	0.000243	0.00437	CbGeAlD
Cyclosporine—FKBP1A—pituitary gland—breast cancer	0.000238	0.00429	CbGeAlD
Cyclosporine—FKBP1A—adipose tissue—breast cancer	0.000237	0.00428	CbGeAlD
Cyclosporine—SLC10A1—endocrine gland—breast cancer	0.000236	0.00426	CbGeAlD
Cyclosporine—ABCB11—endocrine gland—breast cancer	0.000234	0.00421	CbGeAlD
Cyclosporine—CYP3A7—endocrine gland—breast cancer	0.000228	0.00412	CbGeAlD
Cyclosporine—CYP2C9—mammary gland—breast cancer	0.000226	0.00407	CbGeAlD
Cyclosporine—FKBP1A—female reproductive system—breast cancer	0.000218	0.00393	CbGeAlD
Cyclosporine—FKBP1A—adrenal gland—breast cancer	0.000213	0.00384	CbGeAlD
Cyclosporine—ABCC10—endometrium—breast cancer	0.000211	0.0038	CbGeAlD
Cyclosporine—FKBP1A—bone marrow—breast cancer	0.000206	0.00371	CbGeAlD
Cyclosporine—PPIF—lymph node—breast cancer	0.000201	0.00362	CbGeAlD
Cyclosporine—FKBP1A—female gonad—breast cancer	0.000198	0.00358	CbGeAlD
Cyclosporine—ABCC10—uterus—breast cancer	0.000194	0.0035	CbGeAlD
Cyclosporine—PPP3CA—lymph node—breast cancer	0.000192	0.00346	CbGeAlD
Cyclosporine—ABCC3—adipose tissue—breast cancer	0.000191	0.00344	CbGeAlD
Cyclosporine—PPIB—lymph node—breast cancer	0.000191	0.00344	CbGeAlD
Cyclosporine—ABCC10—pituitary gland—breast cancer	0.000191	0.00344	CbGeAlD
Cyclosporine—ABCC10—adipose tissue—breast cancer	0.00019	0.00343	CbGeAlD
Cyclosporine—SLCO1B1—female reproductive system—breast cancer	0.000185	0.00334	CbGeAlD
Cyclosporine—FKBP1A—endocrine gland—breast cancer	0.000185	0.00333	CbGeAlD
Cyclosporine—ABCC3—female reproductive system—breast cancer	0.000176	0.00317	CbGeAlD
Cyclosporine—ABCC10—female reproductive system—breast cancer	0.000175	0.00315	CbGeAlD
Cyclosporine—ABCC3—adrenal gland—breast cancer	0.000171	0.00309	CbGeAlD
Cyclosporine—ABCC10—adrenal gland—breast cancer	0.000171	0.00307	CbGeAlD
Cyclosporine—ABCC10—bone marrow—breast cancer	0.000165	0.00297	CbGeAlD
Cyclosporine—ABCC3—female gonad—breast cancer	0.00016	0.00288	CbGeAlD
Cyclosporine—ABCC10—female gonad—breast cancer	0.000159	0.00287	CbGeAlD
Cyclosporine—SLCO1B1—endocrine gland—breast cancer	0.000157	0.00282	CbGeAlD
Cyclosporine—ABCC1—endometrium—breast cancer	0.000149	0.00269	CbGeAlD
Cyclosporine—ABCC3—endocrine gland—breast cancer	0.000149	0.00268	CbGeAlD
Cyclosporine—ABCC10—endocrine gland—breast cancer	0.000148	0.00267	CbGeAlD
Cyclosporine—ABCC2—female reproductive system—breast cancer	0.00014	0.00253	CbGeAlD
Cyclosporine—ABCC1—uterus—breast cancer	0.000137	0.00248	CbGeAlD
Cyclosporine—ABCC2—adrenal gland—breast cancer	0.000137	0.00247	CbGeAlD
Cyclosporine—ABCC1—pituitary gland—breast cancer	0.000135	0.00243	CbGeAlD
Cyclosporine—ABCC1—adipose tissue—breast cancer	0.000134	0.00242	CbGeAlD
Cyclosporine—FKBP1A—lymph node—breast cancer	0.000128	0.0023	CbGeAlD
Cyclosporine—SLCO1A2—endocrine gland—breast cancer	0.000127	0.0023	CbGeAlD
Cyclosporine—CYP2C8—endometrium—breast cancer	0.000127	0.00229	CbGeAlD
Cyclosporine—ABCG2—endometrium—breast cancer	0.000124	0.00223	CbGeAlD
Cyclosporine—ABCC1—adrenal gland—breast cancer	0.000121	0.00217	CbGeAlD
Cyclosporine—ABCC2—endocrine gland—breast cancer	0.000119	0.00214	CbGeAlD
Cyclosporine—CYP2C8—pituitary gland—breast cancer	0.000115	0.00207	CbGeAlD
Cyclosporine—ABCG2—uterus—breast cancer	0.000114	0.00205	CbGeAlD
Cyclosporine—ABCC1—female gonad—breast cancer	0.000112	0.00203	CbGeAlD
Cyclosporine—ABCG2—pituitary gland—breast cancer	0.000112	0.00201	CbGeAlD
Cyclosporine—ABCG2—adipose tissue—breast cancer	0.000111	0.00201	CbGeAlD
Cyclosporine—CYP2C8—female reproductive system—breast cancer	0.000105	0.0019	CbGeAlD
Cyclosporine—CYP3A5—adipose tissue—breast cancer	0.000103	0.00186	CbGeAlD
Cyclosporine—ABCC3—lymph node—breast cancer	0.000103	0.00185	CbGeAlD
Cyclosporine—ABCC10—lymph node—breast cancer	0.000102	0.00184	CbGeAlD
Cyclosporine—CYP2C19—endocrine gland—breast cancer	0.000102	0.00184	CbGeAlD
Cyclosporine—ABCG2—adrenal gland—breast cancer	9.99e-05	0.0018	CbGeAlD
Cyclosporine—ABCG2—bone marrow—breast cancer	9.66e-05	0.00174	CbGeAlD
Cyclosporine—CYP2C9—female reproductive system—breast cancer	9.35e-05	0.00168	CbGeAlD
Cyclosporine—ABCG2—female gonad—breast cancer	9.31e-05	0.00168	CbGeAlD
Cyclosporine—CYP2C8—endocrine gland—breast cancer	8.91e-05	0.00161	CbGeAlD
Cyclosporine—CYP3A5—female gonad—breast cancer	8.64e-05	0.00156	CbGeAlD
Cyclosporine—ABCB1—embryo—breast cancer	8.32e-05	0.0015	CbGeAlD
Cyclosporine—ABCC2—lymph node—breast cancer	8.21e-05	0.00148	CbGeAlD
Cyclosporine—CYP3A5—endocrine gland—breast cancer	8.04e-05	0.00145	CbGeAlD
Cyclosporine—CYP2C9—endocrine gland—breast cancer	7.91e-05	0.00143	CbGeAlD
Cyclosporine—ABCC1—lymph node—breast cancer	7.23e-05	0.0013	CbGeAlD
Cyclosporine—CYP3A4—female reproductive system—breast cancer	7.13e-05	0.00128	CbGeAlD
Cyclosporine—CYP2D6—female reproductive system—breast cancer	7.01e-05	0.00126	CbGeAlD
Cyclosporine—ABCB1—epithelium—breast cancer	6.79e-05	0.00122	CbGeAlD
Cyclosporine—CYP2D6—female gonad—breast cancer	6.38e-05	0.00115	CbGeAlD
Cyclosporine—ABCB1—endometrium—breast cancer	6.09e-05	0.0011	CbGeAlD
Cyclosporine—CYP3A4—endocrine gland—breast cancer	6.03e-05	0.00109	CbGeAlD
Cyclosporine—ABCG2—lymph node—breast cancer	5.99e-05	0.00108	CbGeAlD
Cyclosporine—CYP2D6—endocrine gland—breast cancer	5.94e-05	0.00107	CbGeAlD
Cyclosporine—ABCB1—uterus—breast cancer	5.61e-05	0.00101	CbGeAlD
Cyclosporine—ABCB1—pituitary gland—breast cancer	5.51e-05	0.000993	CbGeAlD
Cyclosporine—ABCB1—adipose tissue—breast cancer	5.49e-05	0.000989	CbGeAlD
Cyclosporine—ABCB1—female reproductive system—breast cancer	5.05e-05	0.000909	CbGeAlD
Cyclosporine—ABCB1—adrenal gland—breast cancer	4.92e-05	0.000887	CbGeAlD
Cyclosporine—ABCB1—bone marrow—breast cancer	4.76e-05	0.000859	CbGeAlD
Cyclosporine—ABCB1—female gonad—breast cancer	4.59e-05	0.000828	CbGeAlD
Cyclosporine—ABCB1—endocrine gland—breast cancer	4.27e-05	0.00077	CbGeAlD
Cyclosporine—ABCB1—lymph node—breast cancer	2.95e-05	0.000532	CbGeAlD
Cyclosporine—Musculoskeletal discomfort—Capecitabine—breast cancer	1.35e-05	0.0001	CcSEcCtD
Cyclosporine—Flushing—Epirubicin—breast cancer	1.35e-05	0.0001	CcSEcCtD
Cyclosporine—Vomiting—Fluorouracil—breast cancer	1.35e-05	0.0001	CcSEcCtD
Cyclosporine—Rhinitis—Doxorubicin—breast cancer	1.35e-05	0.0001	CcSEcCtD
Cyclosporine—Dyspepsia—Docetaxel—breast cancer	1.35e-05	0.0001	CcSEcCtD
Cyclosporine—Haemorrhage—Doxorubicin—breast cancer	1.34e-05	0.0001	CcSEcCtD
Cyclosporine—Hepatitis—Doxorubicin—breast cancer	1.34e-05	0.0001	CcSEcCtD
Cyclosporine—Insomnia—Capecitabine—breast cancer	1.34e-05	9.97e-05	CcSEcCtD
Cyclosporine—Hypoaesthesia—Doxorubicin—breast cancer	1.34e-05	9.95e-05	CcSEcCtD
Cyclosporine—Rash—Fluorouracil—breast cancer	1.33e-05	9.95e-05	CcSEcCtD
Cyclosporine—Dermatitis—Fluorouracil—breast cancer	1.33e-05	9.94e-05	CcSEcCtD
Cyclosporine—Pharyngitis—Doxorubicin—breast cancer	1.33e-05	9.93e-05	CcSEcCtD
Cyclosporine—Paraesthesia—Capecitabine—breast cancer	1.33e-05	9.9e-05	CcSEcCtD
Cyclosporine—Decreased appetite—Docetaxel—breast cancer	1.33e-05	9.9e-05	CcSEcCtD
Cyclosporine—Hypersensitivity—Paclitaxel—breast cancer	1.33e-05	9.9e-05	CcSEcCtD
Cyclosporine—Headache—Fluorouracil—breast cancer	1.33e-05	9.88e-05	CcSEcCtD
Cyclosporine—Urinary tract disorder—Doxorubicin—breast cancer	1.33e-05	9.88e-05	CcSEcCtD
Cyclosporine—Dysgeusia—Methotrexate—breast cancer	1.32e-05	9.85e-05	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Docetaxel—breast cancer	1.32e-05	9.83e-05	CcSEcCtD
Cyclosporine—Connective tissue disorder—Doxorubicin—breast cancer	1.32e-05	9.83e-05	CcSEcCtD
Cyclosporine—Dyspnoea—Capecitabine—breast cancer	1.32e-05	9.83e-05	CcSEcCtD
Cyclosporine—Fatigue—Docetaxel—breast cancer	1.32e-05	9.82e-05	CcSEcCtD
Cyclosporine—Angiopathy—Epirubicin—breast cancer	1.32e-05	9.81e-05	CcSEcCtD
Cyclosporine—Urethral disorder—Doxorubicin—breast cancer	1.32e-05	9.81e-05	CcSEcCtD
Cyclosporine—Nausea—Irinotecan—breast cancer	1.31e-05	9.79e-05	CcSEcCtD
Cyclosporine—Nausea—Mitoxantrone—breast cancer	1.31e-05	9.79e-05	CcSEcCtD
Cyclosporine—Mediastinal disorder—Epirubicin—breast cancer	1.31e-05	9.74e-05	CcSEcCtD
Cyclosporine—Constipation—Docetaxel—breast cancer	1.31e-05	9.74e-05	CcSEcCtD
Cyclosporine—Pain—Docetaxel—breast cancer	1.31e-05	9.74e-05	CcSEcCtD
Cyclosporine—Dyspepsia—Capecitabine—breast cancer	1.3e-05	9.71e-05	CcSEcCtD
Cyclosporine—Chills—Epirubicin—breast cancer	1.3e-05	9.7e-05	CcSEcCtD
Cyclosporine—Arrhythmia—Epirubicin—breast cancer	1.3e-05	9.66e-05	CcSEcCtD
Cyclosporine—Visual impairment—Doxorubicin—breast cancer	1.29e-05	9.64e-05	CcSEcCtD
Cyclosporine—Asthenia—Paclitaxel—breast cancer	1.29e-05	9.64e-05	CcSEcCtD
Cyclosporine—Decreased appetite—Capecitabine—breast cancer	1.29e-05	9.58e-05	CcSEcCtD
Cyclosporine—Alopecia—Epirubicin—breast cancer	1.28e-05	9.55e-05	CcSEcCtD
Cyclosporine—Nausea—Gemcitabine—breast cancer	1.28e-05	9.53e-05	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Capecitabine—breast cancer	1.28e-05	9.52e-05	CcSEcCtD
Cyclosporine—Fatigue—Capecitabine—breast cancer	1.28e-05	9.51e-05	CcSEcCtD
Cyclosporine—Pruritus—Paclitaxel—breast cancer	1.28e-05	9.51e-05	CcSEcCtD
Cyclosporine—Vision blurred—Methotrexate—breast cancer	1.27e-05	9.48e-05	CcSEcCtD
Cyclosporine—Mental disorder—Epirubicin—breast cancer	1.27e-05	9.47e-05	CcSEcCtD
Cyclosporine—Constipation—Capecitabine—breast cancer	1.27e-05	9.43e-05	CcSEcCtD
Cyclosporine—Pain—Capecitabine—breast cancer	1.27e-05	9.43e-05	CcSEcCtD
Cyclosporine—Malnutrition—Epirubicin—breast cancer	1.26e-05	9.41e-05	CcSEcCtD
Cyclosporine—Feeling abnormal—Docetaxel—breast cancer	1.26e-05	9.38e-05	CcSEcCtD
Cyclosporine—Nausea—Fluorouracil—breast cancer	1.26e-05	9.37e-05	CcSEcCtD
Cyclosporine—Ill-defined disorder—Methotrexate—breast cancer	1.25e-05	9.33e-05	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—breast cancer	1.25e-05	9.33e-05	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Docetaxel—breast cancer	1.25e-05	9.31e-05	CcSEcCtD
Cyclosporine—Anaemia—Methotrexate—breast cancer	1.25e-05	9.3e-05	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—breast cancer	1.25e-05	9.28e-05	CcSEcCtD
Cyclosporine—Flatulence—Epirubicin—breast cancer	1.24e-05	9.27e-05	CcSEcCtD
Cyclosporine—Tension—Epirubicin—breast cancer	1.24e-05	9.24e-05	CcSEcCtD
Cyclosporine—Dysgeusia—Epirubicin—breast cancer	1.24e-05	9.22e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Paclitaxel—breast cancer	1.23e-05	9.19e-05	CcSEcCtD
Cyclosporine—Nervousness—Epirubicin—breast cancer	1.23e-05	9.14e-05	CcSEcCtD
Cyclosporine—Feeling abnormal—Capecitabine—breast cancer	1.22e-05	9.09e-05	CcSEcCtD
Cyclosporine—Angiopathy—Doxorubicin—breast cancer	1.22e-05	9.08e-05	CcSEcCtD
Cyclosporine—Malaise—Methotrexate—breast cancer	1.22e-05	9.07e-05	CcSEcCtD
Cyclosporine—Muscle spasms—Epirubicin—breast cancer	1.21e-05	9.05e-05	CcSEcCtD
Cyclosporine—Vertigo—Methotrexate—breast cancer	1.21e-05	9.04e-05	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Capecitabine—breast cancer	1.21e-05	9.02e-05	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—breast cancer	1.21e-05	9.02e-05	CcSEcCtD
Cyclosporine—Abdominal pain—Docetaxel—breast cancer	1.21e-05	9e-05	CcSEcCtD
Cyclosporine—Body temperature increased—Docetaxel—breast cancer	1.21e-05	9e-05	CcSEcCtD
Cyclosporine—Leukopenia—Methotrexate—breast cancer	1.21e-05	9e-05	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—breast cancer	1.2e-05	8.98e-05	CcSEcCtD
Cyclosporine—Arrhythmia—Doxorubicin—breast cancer	1.2e-05	8.94e-05	CcSEcCtD
Cyclosporine—Dizziness—Paclitaxel—breast cancer	1.19e-05	8.88e-05	CcSEcCtD
Cyclosporine—Vision blurred—Epirubicin—breast cancer	1.19e-05	8.87e-05	CcSEcCtD
Cyclosporine—Alopecia—Doxorubicin—breast cancer	1.19e-05	8.84e-05	CcSEcCtD
Cyclosporine—Cough—Methotrexate—breast cancer	1.18e-05	8.78e-05	CcSEcCtD
Cyclosporine—Mental disorder—Doxorubicin—breast cancer	1.18e-05	8.76e-05	CcSEcCtD
Cyclosporine—Urticaria—Capecitabine—breast cancer	1.18e-05	8.76e-05	CcSEcCtD
Cyclosporine—Ill-defined disorder—Epirubicin—breast cancer	1.17e-05	8.73e-05	CcSEcCtD
Cyclosporine—Abdominal pain—Capecitabine—breast cancer	1.17e-05	8.72e-05	CcSEcCtD
Cyclosporine—Body temperature increased—Capecitabine—breast cancer	1.17e-05	8.72e-05	CcSEcCtD
Cyclosporine—Convulsion—Methotrexate—breast cancer	1.17e-05	8.71e-05	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—breast cancer	1.17e-05	8.71e-05	CcSEcCtD
Cyclosporine—Anaemia—Epirubicin—breast cancer	1.17e-05	8.7e-05	CcSEcCtD
Cyclosporine—Agitation—Epirubicin—breast cancer	1.16e-05	8.65e-05	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—breast cancer	1.15e-05	8.58e-05	CcSEcCtD
Cyclosporine—Chest pain—Methotrexate—breast cancer	1.15e-05	8.56e-05	CcSEcCtD
Cyclosporine—Arthralgia—Methotrexate—breast cancer	1.15e-05	8.56e-05	CcSEcCtD
Cyclosporine—Myalgia—Methotrexate—breast cancer	1.15e-05	8.56e-05	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—breast cancer	1.15e-05	8.55e-05	CcSEcCtD
Cyclosporine—Vomiting—Paclitaxel—breast cancer	1.15e-05	8.54e-05	CcSEcCtD
Cyclosporine—Dysgeusia—Doxorubicin—breast cancer	1.14e-05	8.53e-05	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.14e-05	8.5e-05	CcSEcCtD
Cyclosporine—Malaise—Epirubicin—breast cancer	1.14e-05	8.49e-05	CcSEcCtD
Cyclosporine—Rash—Paclitaxel—breast cancer	1.14e-05	8.47e-05	CcSEcCtD
Cyclosporine—Dermatitis—Paclitaxel—breast cancer	1.14e-05	8.46e-05	CcSEcCtD
Cyclosporine—Discomfort—Methotrexate—breast cancer	1.14e-05	8.46e-05	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—breast cancer	1.13e-05	8.46e-05	CcSEcCtD
Cyclosporine—Vertigo—Epirubicin—breast cancer	1.13e-05	8.46e-05	CcSEcCtD
Cyclosporine—Leukopenia—Epirubicin—breast cancer	1.13e-05	8.42e-05	CcSEcCtD
Cyclosporine—Headache—Paclitaxel—breast cancer	1.13e-05	8.42e-05	CcSEcCtD
Cyclosporine—Hypersensitivity—Docetaxel—breast cancer	1.13e-05	8.39e-05	CcSEcCtD
Cyclosporine—Muscle spasms—Doxorubicin—breast cancer	1.12e-05	8.37e-05	CcSEcCtD
Cyclosporine—Confusional state—Methotrexate—breast cancer	1.11e-05	8.28e-05	CcSEcCtD
Cyclosporine—Cough—Epirubicin—breast cancer	1.1e-05	8.21e-05	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methotrexate—breast cancer	1.1e-05	8.21e-05	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—breast cancer	1.1e-05	8.21e-05	CcSEcCtD
Cyclosporine—Asthenia—Docetaxel—breast cancer	1.1e-05	8.17e-05	CcSEcCtD
Cyclosporine—Convulsion—Epirubicin—breast cancer	1.09e-05	8.15e-05	CcSEcCtD
Cyclosporine—Infection—Methotrexate—breast cancer	1.09e-05	8.15e-05	CcSEcCtD
Cyclosporine—Hypertension—Epirubicin—breast cancer	1.09e-05	8.13e-05	CcSEcCtD
Cyclosporine—Hypersensitivity—Capecitabine—breast cancer	1.09e-05	8.12e-05	CcSEcCtD
Cyclosporine—Ill-defined disorder—Doxorubicin—breast cancer	1.08e-05	8.08e-05	CcSEcCtD
Cyclosporine—Pruritus—Docetaxel—breast cancer	1.08e-05	8.06e-05	CcSEcCtD
Cyclosporine—Nervous system disorder—Methotrexate—breast cancer	1.08e-05	8.05e-05	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—breast cancer	1.08e-05	8.05e-05	CcSEcCtD
Cyclosporine—Thrombocytopenia—Methotrexate—breast cancer	1.08e-05	8.04e-05	CcSEcCtD
Cyclosporine—Arthralgia—Epirubicin—breast cancer	1.08e-05	8.01e-05	CcSEcCtD
Cyclosporine—Chest pain—Epirubicin—breast cancer	1.08e-05	8.01e-05	CcSEcCtD
Cyclosporine—Myalgia—Epirubicin—breast cancer	1.08e-05	8.01e-05	CcSEcCtD
Cyclosporine—Agitation—Doxorubicin—breast cancer	1.07e-05	8e-05	CcSEcCtD
Cyclosporine—Anxiety—Epirubicin—breast cancer	1.07e-05	7.98e-05	CcSEcCtD
Cyclosporine—Nausea—Paclitaxel—breast cancer	1.07e-05	7.98e-05	CcSEcCtD
Cyclosporine—Skin disorder—Methotrexate—breast cancer	1.07e-05	7.97e-05	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.07e-05	7.96e-05	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methotrexate—breast cancer	1.06e-05	7.93e-05	CcSEcCtD
Cyclosporine—Discomfort—Epirubicin—breast cancer	1.06e-05	7.92e-05	CcSEcCtD
Cyclosporine—Asthenia—Capecitabine—breast cancer	1.06e-05	7.91e-05	CcSEcCtD
Cyclosporine—Malaise—Doxorubicin—breast cancer	1.05e-05	7.85e-05	CcSEcCtD
Cyclosporine—Dry mouth—Epirubicin—breast cancer	1.05e-05	7.84e-05	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—breast cancer	1.05e-05	7.82e-05	CcSEcCtD
Cyclosporine—Anorexia—Methotrexate—breast cancer	1.05e-05	7.82e-05	CcSEcCtD
Cyclosporine—Pruritus—Capecitabine—breast cancer	1.05e-05	7.8e-05	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—breast cancer	1.05e-05	7.79e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Docetaxel—breast cancer	1.05e-05	7.79e-05	CcSEcCtD
Cyclosporine—Confusional state—Epirubicin—breast cancer	1.04e-05	7.74e-05	CcSEcCtD
Cyclosporine—Anaphylactic shock—Epirubicin—breast cancer	1.03e-05	7.68e-05	CcSEcCtD
Cyclosporine—Oedema—Epirubicin—breast cancer	1.03e-05	7.68e-05	CcSEcCtD
Cyclosporine—Infection—Epirubicin—breast cancer	1.02e-05	7.63e-05	CcSEcCtD
Cyclosporine—Cough—Doxorubicin—breast cancer	1.02e-05	7.6e-05	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—breast cancer	1.01e-05	7.55e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Capecitabine—breast cancer	1.01e-05	7.54e-05	CcSEcCtD
Cyclosporine—Nervous system disorder—Epirubicin—breast cancer	1.01e-05	7.53e-05	CcSEcCtD
Cyclosporine—Dizziness—Docetaxel—breast cancer	1.01e-05	7.53e-05	CcSEcCtD
Cyclosporine—Thrombocytopenia—Epirubicin—breast cancer	1.01e-05	7.52e-05	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—breast cancer	1.01e-05	7.52e-05	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methotrexate—breast cancer	1e-05	7.48e-05	CcSEcCtD
Cyclosporine—Skin disorder—Epirubicin—breast cancer	1e-05	7.46e-05	CcSEcCtD
Cyclosporine—Hyperhidrosis—Epirubicin—breast cancer	9.96e-06	7.43e-05	CcSEcCtD
Cyclosporine—Insomnia—Methotrexate—breast cancer	9.96e-06	7.42e-05	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—breast cancer	9.95e-06	7.41e-05	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—breast cancer	9.95e-06	7.41e-05	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—breast cancer	9.95e-06	7.41e-05	CcSEcCtD
Cyclosporine—Anxiety—Doxorubicin—breast cancer	9.91e-06	7.39e-05	CcSEcCtD
Cyclosporine—Paraesthesia—Methotrexate—breast cancer	9.89e-06	7.37e-05	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	9.88e-06	7.36e-05	CcSEcCtD
Cyclosporine—Discomfort—Doxorubicin—breast cancer	9.83e-06	7.32e-05	CcSEcCtD
Cyclosporine—Anorexia—Epirubicin—breast cancer	9.82e-06	7.32e-05	CcSEcCtD
Cyclosporine—Dyspnoea—Methotrexate—breast cancer	9.82e-06	7.32e-05	CcSEcCtD
Cyclosporine—Somnolence—Methotrexate—breast cancer	9.79e-06	7.3e-05	CcSEcCtD
Cyclosporine—Dizziness—Capecitabine—breast cancer	9.78e-06	7.29e-05	CcSEcCtD
Cyclosporine—Dry mouth—Doxorubicin—breast cancer	9.73e-06	7.25e-05	CcSEcCtD
Cyclosporine—Vomiting—Docetaxel—breast cancer	9.72e-06	7.24e-05	CcSEcCtD
Cyclosporine—Dyspepsia—Methotrexate—breast cancer	9.69e-06	7.22e-05	CcSEcCtD
Cyclosporine—Rash—Docetaxel—breast cancer	9.63e-06	7.18e-05	CcSEcCtD
Cyclosporine—Dermatitis—Docetaxel—breast cancer	9.63e-06	7.17e-05	CcSEcCtD
Cyclosporine—Confusional state—Doxorubicin—breast cancer	9.62e-06	7.17e-05	CcSEcCtD
Cyclosporine—Decreased appetite—Methotrexate—breast cancer	9.57e-06	7.13e-05	CcSEcCtD
Cyclosporine—Headache—Docetaxel—breast cancer	9.57e-06	7.13e-05	CcSEcCtD
Cyclosporine—Anaphylactic shock—Doxorubicin—breast cancer	9.54e-06	7.11e-05	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—breast cancer	9.54e-06	7.11e-05	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Methotrexate—breast cancer	9.51e-06	7.09e-05	CcSEcCtD
Cyclosporine—Fatigue—Methotrexate—breast cancer	9.49e-06	7.08e-05	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—breast cancer	9.47e-06	7.06e-05	CcSEcCtD
Cyclosporine—Pain—Methotrexate—breast cancer	9.42e-06	7.02e-05	CcSEcCtD
Cyclosporine—Vomiting—Capecitabine—breast cancer	9.41e-06	7.01e-05	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Epirubicin—breast cancer	9.39e-06	7e-05	CcSEcCtD
Cyclosporine—Nervous system disorder—Doxorubicin—breast cancer	9.35e-06	6.97e-05	CcSEcCtD
Cyclosporine—Thrombocytopenia—Doxorubicin—breast cancer	9.34e-06	6.96e-05	CcSEcCtD
Cyclosporine—Rash—Capecitabine—breast cancer	9.33e-06	6.95e-05	CcSEcCtD
Cyclosporine—Insomnia—Epirubicin—breast cancer	9.32e-06	6.95e-05	CcSEcCtD
Cyclosporine—Dermatitis—Capecitabine—breast cancer	9.32e-06	6.95e-05	CcSEcCtD
Cyclosporine—Headache—Capecitabine—breast cancer	9.27e-06	6.91e-05	CcSEcCtD
Cyclosporine—Skin disorder—Doxorubicin—breast cancer	9.26e-06	6.9e-05	CcSEcCtD
Cyclosporine—Paraesthesia—Epirubicin—breast cancer	9.25e-06	6.9e-05	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—breast cancer	9.22e-06	6.87e-05	CcSEcCtD
Cyclosporine—Dyspnoea—Epirubicin—breast cancer	9.19e-06	6.85e-05	CcSEcCtD
Cyclosporine—Somnolence—Epirubicin—breast cancer	9.16e-06	6.83e-05	CcSEcCtD
Cyclosporine—Anorexia—Doxorubicin—breast cancer	9.09e-06	6.77e-05	CcSEcCtD
Cyclosporine—Nausea—Docetaxel—breast cancer	9.08e-06	6.76e-05	CcSEcCtD
Cyclosporine—Feeling abnormal—Methotrexate—breast cancer	9.08e-06	6.76e-05	CcSEcCtD
Cyclosporine—Dyspepsia—Epirubicin—breast cancer	9.07e-06	6.76e-05	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Methotrexate—breast cancer	9.01e-06	6.71e-05	CcSEcCtD
Cyclosporine—Decreased appetite—Epirubicin—breast cancer	8.96e-06	6.68e-05	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Epirubicin—breast cancer	8.9e-06	6.63e-05	CcSEcCtD
Cyclosporine—Fatigue—Epirubicin—breast cancer	8.89e-06	6.62e-05	CcSEcCtD
Cyclosporine—Constipation—Epirubicin—breast cancer	8.81e-06	6.57e-05	CcSEcCtD
Cyclosporine—Pain—Epirubicin—breast cancer	8.81e-06	6.57e-05	CcSEcCtD
Cyclosporine—Nausea—Capecitabine—breast cancer	8.79e-06	6.55e-05	CcSEcCtD
Cyclosporine—Urticaria—Methotrexate—breast cancer	8.75e-06	6.52e-05	CcSEcCtD
Cyclosporine—Abdominal pain—Methotrexate—breast cancer	8.71e-06	6.49e-05	CcSEcCtD
Cyclosporine—Body temperature increased—Methotrexate—breast cancer	8.71e-06	6.49e-05	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—breast cancer	8.69e-06	6.48e-05	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—breast cancer	8.63e-06	6.43e-05	CcSEcCtD
Cyclosporine—Paraesthesia—Doxorubicin—breast cancer	8.56e-06	6.38e-05	CcSEcCtD
Cyclosporine—Dyspnoea—Doxorubicin—breast cancer	8.5e-06	6.34e-05	CcSEcCtD
Cyclosporine—Feeling abnormal—Epirubicin—breast cancer	8.49e-06	6.33e-05	CcSEcCtD
Cyclosporine—Somnolence—Doxorubicin—breast cancer	8.48e-06	6.32e-05	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Epirubicin—breast cancer	8.43e-06	6.28e-05	CcSEcCtD
Cyclosporine—Dyspepsia—Doxorubicin—breast cancer	8.39e-06	6.26e-05	CcSEcCtD
Cyclosporine—Decreased appetite—Doxorubicin—breast cancer	8.29e-06	6.18e-05	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—breast cancer	8.23e-06	6.14e-05	CcSEcCtD
Cyclosporine—Fatigue—Doxorubicin—breast cancer	8.22e-06	6.13e-05	CcSEcCtD
Cyclosporine—Urticaria—Epirubicin—breast cancer	8.19e-06	6.1e-05	CcSEcCtD
Cyclosporine—Pain—Doxorubicin—breast cancer	8.15e-06	6.08e-05	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—breast cancer	8.15e-06	6.08e-05	CcSEcCtD
Cyclosporine—Abdominal pain—Epirubicin—breast cancer	8.15e-06	6.07e-05	CcSEcCtD
Cyclosporine—Body temperature increased—Epirubicin—breast cancer	8.15e-06	6.07e-05	CcSEcCtD
Cyclosporine—Hypersensitivity—Methotrexate—breast cancer	8.11e-06	6.05e-05	CcSEcCtD
Cyclosporine—Asthenia—Methotrexate—breast cancer	7.9e-06	5.89e-05	CcSEcCtD
Cyclosporine—Feeling abnormal—Doxorubicin—breast cancer	7.86e-06	5.86e-05	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Doxorubicin—breast cancer	7.8e-06	5.81e-05	CcSEcCtD
Cyclosporine—Pruritus—Methotrexate—breast cancer	7.79e-06	5.81e-05	CcSEcCtD
Cyclosporine—Hypersensitivity—Epirubicin—breast cancer	7.59e-06	5.66e-05	CcSEcCtD
Cyclosporine—Urticaria—Doxorubicin—breast cancer	7.58e-06	5.65e-05	CcSEcCtD
Cyclosporine—Abdominal pain—Doxorubicin—breast cancer	7.54e-06	5.62e-05	CcSEcCtD
Cyclosporine—Body temperature increased—Doxorubicin—breast cancer	7.54e-06	5.62e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Methotrexate—breast cancer	7.54e-06	5.62e-05	CcSEcCtD
Cyclosporine—Asthenia—Epirubicin—breast cancer	7.39e-06	5.51e-05	CcSEcCtD
Cyclosporine—Pruritus—Epirubicin—breast cancer	7.29e-06	5.43e-05	CcSEcCtD
Cyclosporine—Dizziness—Methotrexate—breast cancer	7.28e-06	5.43e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Epirubicin—breast cancer	7.05e-06	5.26e-05	CcSEcCtD
Cyclosporine—Hypersensitivity—Doxorubicin—breast cancer	7.03e-06	5.24e-05	CcSEcCtD
Cyclosporine—Vomiting—Methotrexate—breast cancer	7e-06	5.22e-05	CcSEcCtD
Cyclosporine—Rash—Methotrexate—breast cancer	6.94e-06	5.18e-05	CcSEcCtD
Cyclosporine—Dermatitis—Methotrexate—breast cancer	6.94e-06	5.17e-05	CcSEcCtD
Cyclosporine—Headache—Methotrexate—breast cancer	6.9e-06	5.14e-05	CcSEcCtD
Cyclosporine—Asthenia—Doxorubicin—breast cancer	6.84e-06	5.1e-05	CcSEcCtD
Cyclosporine—Dizziness—Epirubicin—breast cancer	6.82e-06	5.08e-05	CcSEcCtD
Cyclosporine—Pruritus—Doxorubicin—breast cancer	6.75e-06	5.03e-05	CcSEcCtD
Cyclosporine—Vomiting—Epirubicin—breast cancer	6.55e-06	4.88e-05	CcSEcCtD
Cyclosporine—Nausea—Methotrexate—breast cancer	6.54e-06	4.88e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—breast cancer	6.52e-06	4.86e-05	CcSEcCtD
Cyclosporine—Rash—Epirubicin—breast cancer	6.5e-06	4.84e-05	CcSEcCtD
Cyclosporine—Dermatitis—Epirubicin—breast cancer	6.49e-06	4.84e-05	CcSEcCtD
Cyclosporine—Headache—Epirubicin—breast cancer	6.46e-06	4.81e-05	CcSEcCtD
Cyclosporine—Dizziness—Doxorubicin—breast cancer	6.31e-06	4.7e-05	CcSEcCtD
Cyclosporine—Nausea—Epirubicin—breast cancer	6.12e-06	4.56e-05	CcSEcCtD
Cyclosporine—Vomiting—Doxorubicin—breast cancer	6.06e-06	4.52e-05	CcSEcCtD
Cyclosporine—Rash—Doxorubicin—breast cancer	6.01e-06	4.48e-05	CcSEcCtD
Cyclosporine—Dermatitis—Doxorubicin—breast cancer	6.01e-06	4.48e-05	CcSEcCtD
Cyclosporine—Headache—Doxorubicin—breast cancer	5.97e-06	4.45e-05	CcSEcCtD
Cyclosporine—Nausea—Doxorubicin—breast cancer	5.66e-06	4.22e-05	CcSEcCtD
Cyclosporine—CYP2D6—Metabolism—NQO1—breast cancer	8.57e-07	8.69e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ITPR1—breast cancer	8.57e-07	8.69e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—HSP90AA1—breast cancer	8.55e-07	8.67e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NCOA1—breast cancer	8.52e-07	8.64e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SLC2A1—breast cancer	8.5e-07	8.61e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NQO1—breast cancer	8.5e-07	8.61e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CD—breast cancer	8.42e-07	8.53e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—STK11—breast cancer	8.4e-07	8.52e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP19A1—breast cancer	8.4e-07	8.52e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP3A4—breast cancer	8.36e-07	8.47e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PIK3CA—breast cancer	8.35e-07	8.47e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CD—breast cancer	8.34e-07	8.46e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CB—breast cancer	8.34e-07	8.45e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	8.32e-07	8.44e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NCOA1—breast cancer	8.32e-07	8.43e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ALB—breast cancer	8.31e-07	8.42e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP3A4—breast cancer	8.29e-07	8.4e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTGS2—breast cancer	8.26e-07	8.38e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	8.24e-07	8.36e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ABCB1—breast cancer	8.24e-07	8.36e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ALB—breast cancer	8.24e-07	8.35e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP1B1—breast cancer	8.22e-07	8.33e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—STK11—breast cancer	8.2e-07	8.31e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP19A1—breast cancer	8.2e-07	8.31e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—MTHFR—breast cancer	8.17e-07	8.28e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP1B1—breast cancer	8.15e-07	8.26e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—TYMS—breast cancer	8.1e-07	8.21e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—breast cancer	8.08e-07	8.19e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—HSP90AA1—breast cancer	8.06e-07	8.17e-06	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTEN—breast cancer	8.01e-07	8.12e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PLA2G4A—breast cancer	8e-07	8.11e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTM1—breast cancer	8e-07	8.11e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—NCOR1—breast cancer	8e-07	8.11e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—HSP90AA1—breast cancer	7.99e-07	8.1e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SRC—breast cancer	7.98e-07	8.09e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—NOS3—breast cancer	7.95e-07	8.06e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CB—breast cancer	7.92e-07	8.03e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.89e-07	7.99e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—NOS3—breast cancer	7.88e-07	7.99e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTGS2—breast cancer	7.85e-07	7.96e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NCOA1—breast cancer	7.84e-07	7.95e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—COMT—breast cancer	7.81e-07	7.92e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTP1—breast cancer	7.77e-07	7.88e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NCOA1—breast cancer	7.77e-07	7.88e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—STK11—breast cancer	7.73e-07	7.83e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP19A1—breast cancer	7.73e-07	7.83e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—HRAS—breast cancer	7.73e-07	7.83e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—STAT3—breast cancer	7.69e-07	7.8e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—HMOX1—breast cancer	7.67e-07	7.77e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GPX1—breast cancer	7.66e-07	7.77e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—STK11—breast cancer	7.66e-07	7.76e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP19A1—breast cancer	7.66e-07	7.76e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ITPR1—breast cancer	7.65e-07	7.75e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—DPYD—breast cancer	7.63e-07	7.73e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—MED12—breast cancer	7.63e-07	7.73e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—COMT—breast cancer	7.62e-07	7.73e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTP1—breast cancer	7.59e-07	7.69e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP1A1—breast cancer	7.59e-07	7.69e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CAV1—breast cancer	7.53e-07	7.64e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ERCC2—breast cancer	7.52e-07	7.63e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALDOA—breast cancer	7.51e-07	7.61e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—HMOX1—breast cancer	7.48e-07	7.58e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ITPR1—breast cancer	7.47e-07	7.57e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL6—breast cancer	7.39e-07	7.5e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ABCB1—breast cancer	7.36e-07	7.46e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MAPK3—breast cancer	7.35e-07	7.45e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CB—breast cancer	7.34e-07	7.44e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NCOA3—breast cancer	7.29e-07	7.39e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CB—breast cancer	7.27e-07	7.37e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTGS2—breast cancer	7.27e-07	7.37e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC2A2—breast cancer	7.24e-07	7.34e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—TYMS—breast cancer	7.23e-07	7.33e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTGS2—breast cancer	7.21e-07	7.3e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTEN—breast cancer	7.2e-07	7.3e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.19e-07	7.29e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—COMT—breast cancer	7.18e-07	7.28e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—breast cancer	7.15e-07	7.25e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTP1—breast cancer	7.15e-07	7.25e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PLA2G4A—breast cancer	7.14e-07	7.24e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NCOR1—breast cancer	7.14e-07	7.24e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTM1—breast cancer	7.14e-07	7.24e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—TGFB1—breast cancer	7.13e-07	7.23e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—COMT—breast cancer	7.12e-07	7.22e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ABCG2—breast cancer	7.09e-07	7.19e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—MTR—breast cancer	7.09e-07	7.19e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CPT1A—breast cancer	7.09e-07	7.19e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTP1—breast cancer	7.09e-07	7.18e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—MTHFR—breast cancer	7.07e-07	7.17e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—TYMS—breast cancer	7.05e-07	7.15e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—HMOX1—breast cancer	7.05e-07	7.15e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ITPR1—breast cancer	7.03e-07	7.13e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EGFR—breast cancer	6.99e-07	7.09e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—HMOX1—breast cancer	6.99e-07	7.09e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ITPR1—breast cancer	6.97e-07	7.07e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NCOR1—breast cancer	6.97e-07	7.07e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTM1—breast cancer	6.97e-07	7.07e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PLA2G4A—breast cancer	6.97e-07	7.07e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HPGDS—breast cancer	6.95e-07	7.05e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HBA1—breast cancer	6.91e-07	7e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CG—breast cancer	6.86e-07	6.95e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTEN—breast cancer	6.85e-07	6.94e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GPX1—breast cancer	6.84e-07	6.93e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—AKT1—breast cancer	6.82e-07	6.92e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP1A1—breast cancer	6.77e-07	6.86e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ABCB1—breast cancer	6.77e-07	6.86e-06	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CA—breast cancer	6.77e-07	6.86e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTT1—breast cancer	6.74e-07	6.84e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ACHE—breast cancer	6.74e-07	6.84e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ERCC2—breast cancer	6.72e-07	6.81e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ABCB1—breast cancer	6.71e-07	6.8e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GPX1—breast cancer	6.68e-07	6.77e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—TYMS—breast cancer	6.65e-07	6.74e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP1A1—breast cancer	6.61e-07	6.7e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—breast cancer	6.61e-07	6.7e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—TYMS—breast cancer	6.59e-07	6.68e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NCOR1—breast cancer	6.57e-07	6.66e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PLA2G4A—breast cancer	6.57e-07	6.66e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTM1—breast cancer	6.57e-07	6.66e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ERCC2—breast cancer	6.55e-07	6.64e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CAV1—breast cancer	6.52e-07	6.61e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PLA2G4A—breast cancer	6.51e-07	6.6e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTM1—breast cancer	6.51e-07	6.6e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NCOR1—breast cancer	6.51e-07	6.6e-06	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CA—breast cancer	6.49e-07	6.58e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP17A1—breast cancer	6.38e-07	6.47e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTEN—breast cancer	6.34e-07	6.43e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS1—breast cancer	6.32e-07	6.41e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ENO1—breast cancer	6.32e-07	6.41e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—MTHFR—breast cancer	6.31e-07	6.4e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GPX1—breast cancer	6.29e-07	6.38e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTEN—breast cancer	6.28e-07	6.37e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GPX1—breast cancer	6.24e-07	6.32e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.23e-07	6.32e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP1A1—breast cancer	6.23e-07	6.31e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP2D6—breast cancer	6.2e-07	6.28e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ERCC2—breast cancer	6.18e-07	6.26e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP1A1—breast cancer	6.17e-07	6.26e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—MTHFR—breast cancer	6.16e-07	6.25e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ERCC2—breast cancer	6.12e-07	6.21e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NCOA2—breast cancer	6.08e-07	6.17e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CA—breast cancer	6.07e-07	6.15e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CD—breast cancer	6.03e-07	6.11e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ALB—breast cancer	5.95e-07	6.04e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CG—breast cancer	5.94e-07	6.02e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—FASN—breast cancer	5.9e-07	5.98e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—BCHE—breast cancer	5.87e-07	5.96e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CAV1—breast cancer	5.82e-07	5.9e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—MTHFR—breast cancer	5.81e-07	5.89e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC5A5—breast cancer	5.8e-07	5.88e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—MTHFR—breast cancer	5.76e-07	5.84e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—NOS3—breast cancer	5.69e-07	5.77e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CAV1—breast cancer	5.68e-07	5.76e-06	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CA—breast cancer	5.65e-07	5.73e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HRAS—breast cancer	5.62e-07	5.69e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC2A1—breast cancer	5.6e-07	5.68e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NQO1—breast cancer	5.6e-07	5.68e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.56e-07	5.64e-06	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—AKT1—breast cancer	5.53e-07	5.6e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—IL6—breast cancer	5.37e-07	5.45e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP1B1—breast cancer	5.37e-07	5.45e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CAV1—breast cancer	5.36e-07	5.43e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CAV1—breast cancer	5.31e-07	5.38e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CG—breast cancer	5.3e-07	5.38e-06	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—AKT1—breast cancer	5.3e-07	5.37e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HSP90AA1—breast cancer	5.27e-07	5.34e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CB—breast cancer	5.26e-07	5.33e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CD—breast cancer	5.22e-07	5.3e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS2—breast cancer	5.21e-07	5.28e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CG—breast cancer	5.18e-07	5.25e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ALB—breast cancer	5.16e-07	5.23e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NCOA1—breast cancer	5.13e-07	5.2e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CA—breast cancer	5.08e-07	5.15e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.07e-07	5.14e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—STK11—breast cancer	5.05e-07	5.12e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP19A1—breast cancer	5.05e-07	5.12e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—AKT1—breast cancer	4.96e-07	5.03e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—NOS3—breast cancer	4.93e-07	5e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CG—breast cancer	4.88e-07	4.95e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CG—breast cancer	4.84e-07	4.9e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CA—breast cancer	4.83e-07	4.9e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—COMT—breast cancer	4.7e-07	4.76e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTP1—breast cancer	4.67e-07	4.74e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CD—breast cancer	4.66e-07	4.73e-06	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—AKT1—breast cancer	4.61e-07	4.68e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HMOX1—breast cancer	4.61e-07	4.67e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ALB—breast cancer	4.6e-07	4.67e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ITPR1—breast cancer	4.6e-07	4.66e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CB—breast cancer	4.55e-07	4.62e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CD—breast cancer	4.55e-07	4.61e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTEN—breast cancer	4.54e-07	4.6e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS2—breast cancer	4.51e-07	4.57e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ALB—breast cancer	4.49e-07	4.55e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CA—breast cancer	4.47e-07	4.53e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CA—breast cancer	4.43e-07	4.49e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ABCB1—breast cancer	4.42e-07	4.49e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NOS3—breast cancer	4.4e-07	4.46e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—TYMS—breast cancer	4.35e-07	4.41e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NOS3—breast cancer	4.3e-07	4.36e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NCOR1—breast cancer	4.3e-07	4.35e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTM1—breast cancer	4.3e-07	4.35e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PLA2G4A—breast cancer	4.3e-07	4.35e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CD—breast cancer	4.29e-07	4.35e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CD—breast cancer	4.25e-07	4.31e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ALB—breast cancer	4.23e-07	4.29e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ALB—breast cancer	4.2e-07	4.25e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—AKT1—breast cancer	4.15e-07	4.21e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GPX1—breast cancer	4.11e-07	4.17e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP1A1—breast cancer	4.07e-07	4.13e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CB—breast cancer	4.06e-07	4.12e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NOS3—breast cancer	4.05e-07	4.11e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ERCC2—breast cancer	4.04e-07	4.09e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS2—breast cancer	4.03e-07	4.08e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NOS3—breast cancer	4.01e-07	4.07e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CB—breast cancer	3.97e-07	4.02e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—AKT1—breast cancer	3.95e-07	4e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTEN—breast cancer	3.93e-07	3.99e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS2—breast cancer	3.93e-07	3.98e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—MTHFR—breast cancer	3.8e-07	3.85e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CB—breast cancer	3.74e-07	3.79e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CB—breast cancer	3.71e-07	3.76e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS2—breast cancer	3.7e-07	3.75e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS2—breast cancer	3.67e-07	3.72e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—AKT1—breast cancer	3.65e-07	3.7e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—AKT1—breast cancer	3.62e-07	3.67e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTEN—breast cancer	3.51e-07	3.56e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CAV1—breast cancer	3.5e-07	3.55e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTEN—breast cancer	3.43e-07	3.47e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTEN—breast cancer	3.23e-07	3.27e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CA—breast cancer	3.2e-07	3.25e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTEN—breast cancer	3.2e-07	3.25e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CG—breast cancer	3.19e-07	3.23e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CD—breast cancer	2.8e-07	2.84e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CA—breast cancer	2.78e-07	2.81e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALB—breast cancer	2.77e-07	2.81e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NOS3—breast cancer	2.65e-07	2.68e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AKT1—breast cancer	2.62e-07	2.65e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CA—breast cancer	2.48e-07	2.51e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CB—breast cancer	2.44e-07	2.48e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS2—breast cancer	2.42e-07	2.45e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CA—breast cancer	2.42e-07	2.45e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CA—breast cancer	2.28e-07	2.31e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AKT1—breast cancer	2.27e-07	2.3e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CA—breast cancer	2.26e-07	2.29e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTEN—breast cancer	2.11e-07	2.14e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKT1—breast cancer	2.02e-07	2.05e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKT1—breast cancer	1.98e-07	2e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKT1—breast cancer	1.86e-07	1.89e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKT1—breast cancer	1.85e-07	1.87e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CA—breast cancer	1.49e-07	1.51e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKT1—breast cancer	1.22e-07	1.23e-06	CbGpPWpGaD
